# Celldex Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:833aa779-27d5-474d-a159-7eb59f3dc3cb | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/celldex-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-23T04:46:13.011967+00:00 | | Last reviewed | 2026-10-23T04:46:13.011967+00:00 | ## Identity - Legal name: Celldex Therapeutics, Inc. - Display name: Celldex Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-24T02:44:20.891263+00:00 | | Completeness | 0.409 | | Record Quality | 0.834 | | Directors | 11 | | Committees | 1 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Cheryl L. Cohen: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:7 - Denice Torres: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:8 - Garry A. Neil: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:9 - Herbert J. Conrad: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:11 - James J. Marino: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:12 - Keith L. Brownlie: Director. Status: current. Independent: NOT_PUBLISHED. Since: 1997-01-01. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:13 - Rita I. Jain: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:14 - Anthony S. Marucci: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:6 - Garry A. Neil, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:10 - Harry H. Penner, Jr.: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:5 - Rita I. Jain, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:15 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Anthony S. Marucci (member, unknown). committee_id=alpha:committee:celldex-therapeutics-inc:chief-executive-officer-and-director ## Executive leadership - Elaine D. Crowley: Senior Vice President, Chief Product Development Officer. Status: current. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:17 - Margo Heath-Chiozzi: Senior Vice President, Regulatory Affairs. Status: current. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:19 - Tibor Keler: Executive Vice President and Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:22 - Anthony S. Marucci: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:16 - Elizabeth Crowley: Senior Vice President and Chief Product Development Officer. Status: unknown. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:18 - Margo Heath-Chiozzi, M.D.: Senior Vice President, Regulatory Affairs. Status: unknown. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:20 - Sam Martin: Senior Vice President, Chief Financial Officer and Secretary [CFO]. Status: unknown. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:21 - Tibor Keler, Ph.D.: Executive Vice President and Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:23 ## Governance events - DIRECTOR_APPOINTED: Cheryl L. Cohen seat on Celldex Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:xrha841r5cxaq - DIRECTOR_APPOINTED: Garry A. Neil seat on Celldex Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:1plsooqtp3tpo - DIRECTOR_APPOINTED: Herbert J. Conrad seat on Celldex Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:17gugw51ff4dah - DIRECTOR_APPOINTED: James J. Marino seat on Celldex Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:179p76qcqbpo2 - EXECUTIVE_APPOINTED: Elaine D. Crowley executive of Celldex Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:1927pxtwzhlpz - EXECUTIVE_APPOINTED: Margo Heath-Chiozzi executive of Celldex Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:1vke4ps1ciq022 - EXECUTIVE_APPOINTED: Tibor Keler executive of Celldex Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:ysehhz1xqzf1t - DIRECTOR_APPOINTED: Rita I. Jain seat on Celldex Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:1cbmmwf17g15hj - DIRECTOR_APPOINTED: Denice Torres seat on Celldex Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:6yb2bu1ujfup4 - DIRECTOR_APPOINTED: Keith L. Brownlie seat on Celldex Therapeutics, Inc., effective 1997-01-01. Effective: 1997-01-01. Detected: 2026-10-23T04:46:13.011967+00:00. event_id=alpha:event:transition:je0xl443arzo ## Scoped resources - `alpha://company/celldex-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record - `alpha://company/celldex-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=identity - `alpha://company/celldex-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/celldex-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=board - `alpha://company/celldex-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=committees - `alpha://company/celldex-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=leadership - `alpha://company/celldex-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=ownership - `alpha://company/celldex-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=financials - `alpha://company/celldex-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/celldex-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=compensation - `alpha://company/celldex-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=governance - `alpha://company/celldex-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/celldex-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=audit - `alpha://company/celldex-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=legal - `alpha://company/celldex-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=risk - `alpha://company/celldex-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=cyber - `alpha://company/celldex-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/celldex-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=agents - `alpha://company/celldex-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/celldex-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=events - `alpha://company/celldex-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=relationships - `alpha://company/celldex-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=assessments - `alpha://company/celldex-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Harry H. Penner, Jr.: Chairman of the Board. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Anthony S. Marucci: President, Chief Executive Officer and Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Cheryl L. Cohen: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:7. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2. - Denice Torres: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:8. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2. - Garry A. Neil: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:9. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2. - Garry A. Neil, M.D.: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Herbert J. Conrad: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:11. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2. - James J. Marino: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:12. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2. - Keith L. Brownlie: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:13. Valid from: 1997-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2. - Rita I. Jain: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:14. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2. - Rita I. Jain, M.D.: Director. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Anthony S. Marucci: President and Chief Executive Officer. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Elaine D. Crowley: Senior Vice President, Chief Product Development Officer. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:17. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:34003809804f2faf6e10f1eb9a451420d76fca13cefebfde8b1359f902fae5f7. - Elizabeth Crowley: Senior Vice President and Chief Product Development Officer. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Margo Heath-Chiozzi: Senior Vice President, Regulatory Affairs. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:19. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:641ff768b6fee2c9f30e6fcf263c17a6bcccb3fb31fa3c76822dede0694a13f1. - Margo Heath-Chiozzi, M.D.: Senior Vice President, Regulatory Affairs. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Sam Martin: Senior Vice President, Chief Financial Officer and Secretary. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. - Tibor Keler: Executive Vice President and Chief Scientific Officer. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:22. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:52abee45677a807c0840eb582df379d8f188f10097da83dfd24627ff7f14c898. - Tibor Keler, Ph.D.: Executive Vice President and Chief Scientific Officer. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Celldex Therapeutics, Inc.. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5bd4d38075da9aacb674eac7b580074689e07592e327ac68c35feef602957535. ## Entity Status - Public listing published. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5bd4d38075da9aacb674eac7b580074689e07592e327ac68c35feef602957535. ## Published Fact - US. Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5bd4d38075da9aacb674eac7b580074689e07592e327ac68c35feef602957535. ## Security Listing - CLDX (NASDAQ). Claim: alpha:claim:company:833aa779-27d5-474d-a159-7eb59f3dc3cb:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:5bd4d38075da9aacb674eac7b580074689e07592e327ac68c35feef602957535. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:5bd4d38075da9aacb674eac7b580074689e07592e327ac68c35feef602957535: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/celldex-therapeutics-inc). - alpha:projection-evidence:document:9acea6dba0f01a1189a84a67196c5abe7e1b9c9923852271b2e5914b46ac4214: [SEC DEF 14A 0001104659-26-050884](https://www.sec.gov/Archives/edgar/data/744218/000110465926050884/tm261321-3_def14a.htm). - alpha:projection-evidence:document:702fd75fe9e7a50ad9eeaca0e871dd2df5f7e3d6c0c16bc6d266fa0c873dd0a2: [DEF 14A tm261321-3_def14a.htm](https://www.sec.gov/Archives/edgar/data/744218/000110465926050884/tm261321-3_def14a.htm). - alpha:projection-evidence:document:34003809804f2faf6e10f1eb9a451420d76fca13cefebfde8b1359f902fae5f7: [CLDX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/744218/000110465926050884/tm261321-3_def14a.htm). - alpha:projection-evidence:document:641ff768b6fee2c9f30e6fcf263c17a6bcccb3fb31fa3c76822dede0694a13f1: [CLDX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/744218/000110465926050884/tm261321-3_def14a.htm). - alpha:projection-evidence:document:52abee45677a807c0840eb582df379d8f188f10097da83dfd24627ff7f14c898: [CLDX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/744218/000110465926050884/tm261321-3_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/celldex-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/celldex-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/celldex-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/celldex-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-24T02:44:20.549677+00:00; recorded 2026-10-24T02:44:20.549677+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.